Published in Lancet on December 11, 2007
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol (2012) 3.87
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell (2008) 2.65
Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial. Circulation (2011) 2.44
Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal data. BMJ (2014) 2.34
Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol (2014) 2.33
The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res (2011) 2.26
Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model. BMJ (2013) 1.81
Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health (2008) 1.67
Using the INDEPTH HDSS to build capacity for chronic non-communicable disease risk factor surveillance in low and middle-income countries. Glob Health Action (2009) 1.60
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Tackling the growing diabetes burden in Sub-Saharan Africa: a framework for enhancing outcomes in stroke patients. J Neurol Sci (2014) 1.46
Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years. BMC Health Serv Res (2010) 1.43
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation (2016) 1.40
Association of hypertension and hyperglycaemia with socioeconomic contexts in resource-poor settings: the Bangladesh Demographic and Health Survey. Int J Epidemiol (2015) 1.39
Averting obesity and type 2 diabetes in India through sugar-sweetened beverage taxation: an economic-epidemiologic modeling study. PLoS Med (2014) 1.39
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One (2011) 1.34
Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles. Bull World Health Organ (2011) 1.23
Blood pressure in adult rural INDEPTH population in Asia. Glob Health Action (2009) 1.16
Priorities for developing countries in the global response to non-communicable diseases. Global Health (2012) 1.13
Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One (2012) 1.10
Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health (2010) 1.08
The effect of tobacco control measures during a period of rising cardiovascular disease risk in India: a mathematical model of myocardial infarction and stroke. PLoS Med (2013) 1.04
Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles. Cardiovasc Diabetol (2009) 1.03
Guest Editorial: Strengthening NCD prevention through risk factor surveillance. Glob Health Action (2009) 1.02
Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eff Resour Alloc (2009) 1.02
Commentary: Jumping the gun or asleep at the switch: is there a middle ground? Int J Epidemiol (2013) 1.00
The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials. PLoS One (2012) 1.00
Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam. Int J Hypertens (2012) 0.97
Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open (2013) 0.94
Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis (2008) 0.93
Age and sex pattern of cardiovascular mortality, hospitalisation and associated cost in India. PLoS One (2013) 0.91
Scaling up chronic disease prevention interventions in lower- and middle-income countries. Annu Rev Public Health (2013) 0.91
The role of law and governance reform in the global response to non-communicable diseases. Global Health (2014) 0.91
Risk factor control in secondary prevention of cardiovascular disease: results from the multi-ethnic HELIUS study. Neth Heart J (2017) 0.91
The societal benefits of reducing six behavioural risk factors: an economic modelling study from Australia. BMC Public Health (2011) 0.90
The politics of non-communicable diseases in the global South. Health Place (2015) 0.89
Evaluation of a pilot hypertension management programme for Guatemalan adults. Health Promot Int (2015) 0.89
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med (2015) 0.89
Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study. BMC Public Health (2012) 0.88
Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa. PLoS One (2014) 0.87
Introducing a model of cardiovascular prevention in Nairobi's slums by integrating a public health and private-sector approach: the SCALE-UP study. Glob Health Action (2013) 0.86
Hypertension control in industrial employees: findings from SHIMSCO study. ARYA Atheroscler (2012) 0.85
The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS One (2014) 0.85
Understanding chronic non-communicable diseases in Latin America: towards an equity-based research agenda. Global Health (2011) 0.85
Risk assessment and aspirin use in Asian and Western populations. Vasc Health Risk Manag (2010) 0.84
Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis. Circ Cardiovasc Qual Outcomes (2015) 0.83
Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia. PLoS One (2014) 0.83
Women and NCDs: overcoming the neglect. Glob Health Action (2014) 0.83
Prevalence and determinants of cardiovascular disease risk factors among the residents of urban community housing projects in Malaysia. BMC Public Health (2014) 0.82
Prevalence of Active and Passive Smoking among Adult Population: Findings of a Population-Based Survey in Kerman (KERCADRS), Iran. Addict Health (2016) 0.82
Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study. BMC Health Serv Res (2014) 0.80
Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment. Circulation (2016) 0.80
Education, household wealth and blood pressure in Albania, Armenia, Azerbaijan and Ukraine: findings from the Demographic Health Surveys, 2005-2009. Eur J Intern Med (2012) 0.80
Distribution of Short-Term and Lifetime Predicted Risks of Cardiovascular Diseases in Peruvian Adults. J Am Heart Assoc (2015) 0.79
Economic aspects of chronic diseases in Vietnam. Glob Health Action (2009) 0.78
High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population. Int J Prev Med (2016) 0.78
Pensions and the health of older people in South Africa: is there an effect? J Dev Stud (2014) 0.78
Differences and similarities in explanatory models of hypertension in the United States of america, Tanzania and Jamaica. West Indian Med J (2014) 0.78
Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites. Crit Pathw Cardiol (2015) 0.77
Premature Mortality from Cardiovascular Disease in the Americas - Will the Goal of a Decline of "25% by 2025" be Met? PLoS One (2015) 0.77
A priority health index identifies the top six priority risk and related factors for non-communicable diseases in Brazilian cities. BMC Public Health (2015) 0.77
Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers. Glob Health Action (2016) 0.77
Disease Prevention: The moving target of global cardiovascular health. Nat Rev Cardiol (2009) 0.77
Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules. F1000Res (2016) 0.75
Outcomes and costs of implementing a community-based intervention for hypertension in an urban slum in Kenya. Bull World Health Organ (2016) 0.75
The effect of hypertension and diabetes management in Southwest China: a before- and after-intervention study. PLoS One (2014) 0.75
Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT). PLoS One (2015) 0.75
Financial Burden and Impoverishment Due to Cardiovascular Medications in Low and Middle Income Countries: An Illustration from India. PLoS One (2016) 0.75
Does preservation of the sub-valvular apparatus during mitral valve replacement affect long-term survival and quality of life? A Microsimulation Study. J Cardiothorac Surg (2008) 0.75
The Importance of Global Health Experiences in the Development of New Cardiologists. J Am Coll Cardiol (2016) 0.75
Fixed-dose combination therapy for the prevention of cardiovascular disease. Cochrane Database Syst Rev (2012) 0.75
Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania. PLoS One (2017) 0.75
Subclinical Cerebrovascular Disease Increases the Risk of Incident Stroke and Mortality: The Northern Manhattan Study. J Am Heart Assoc (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Global health 2035: a world converging within a generation. Lancet (2013) 16.85
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Towards a common definition of global health. Lancet (2009) 12.36
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Global burden of blood-pressure-related disease, 2001. Lancet (2008) 11.09
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet (2010) 9.90
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet (2011) 8.19
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol (2006) 5.60
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. Lancet (2009) 5.23
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet (2003) 5.17
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet (2005) 5.13
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA (2013) 4.82
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev (2012) 4.71
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Chronic diseases and injuries in India. Lancet (2011) 4.27
Burden of non-communicable diseases in South Asia. BMJ (2004) 4.19
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18
Noncommunicable diseases. N Engl J Med (2013) 4.17
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13
A systematic analysis of global anemia burden from 1990 to 2010. Blood (2013) 3.94
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Improvement of child survival in Mexico: the diagonal approach. Lancet (2006) 3.87
Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev (2009) 3.70
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68
Strengthening health information systems to address health equity challenges. Bull World Health Organ (2005) 3.46
Assessment of population-level effect of Avahan, an HIV-prevention initiative in India. Lancet (2011) 3.39
Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet (2006) 3.33
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
Scaling up interventions for chronic disease prevention: the evidence. Lancet (2007) 3.24
Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med (2010) 3.16
Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens (2006) 3.12
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr (2011) 3.10
Benchmarking of performance of Mexican states with effective coverage. Lancet (2006) 3.06
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol (2005) 2.86
Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr (2003) 2.80
Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr (2010) 2.67
The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS (2013) 2.66
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Honey as a topical treatment for wounds. Cochrane Database Syst Rev (2008) 2.64
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet (2011) 2.61
Effects of active video games on body composition: a randomized controlled trial. Am J Clin Nutr (2011) 2.61
Measuring progress on NCDs: one goal and five targets. Lancet (2012) 2.55
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ (2005) 2.54
Cardiovascular risk factor prevalence among men in a large industry of northern India. Natl Med J India (2005) 2.54
Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ (2008) 2.48
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
A multimedia mobile phone-based youth smoking cessation intervention: findings from content development and piloting studies. J Med Internet Res (2008) 2.46
Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens (2006) 2.43
Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37
China's health system performance. Lancet (2008) 2.36
Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment. Lancet (2006) 2.35
Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006. PLoS Med (2010) 2.32
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation (2013) 2.31
Redefining Blood-Pressure Targets--SPRINT Starts the Marathon. N Engl J Med (2015) 2.30
Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses. Lancet (2007) 2.30
Maintaining confidentiality of interim data to enhance trial integrity and credibility. Clin Trials (2008) 2.26
A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One (2011) 2.23